Brought to you by 
Heart failure device approval triggers St. Jude option exercise for CardioMEMS
10 Sep 2020
Executive Summary
Less than four years after taking a 19% equity stake in CardioMEMS Inc. for $60mm, St. Jude Medical Inc. exercised its exclusive option to acquire the remaining 81% of the shares of the private cardiac monitoring company for $375mm.
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
- Implantable Devices
- Monitoring Equipment & Devices
- Radiofrequency Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Heart failure device approval triggers St. Jude option exercise for CardioMEMS
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice